For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...
Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...
Background Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) among young individuals and ...
To inform continued development of the novel immune agent GEN-1, we compared ovarian cancer patients' end points from a neoadjuvant single-arm phase IB study with those of similar historic clinical ...
News-Medical.Net on MSN
Calcium supplements do not prevent pre-eclampsia, large trials show no meaningful benefit
By Dr. Liji Thomas, MD A new Cochrane systematic review of 10 randomised trials involving over 37,000 pregnant women found ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback